Windlas Biotech IPO: Earning opportunity from August 4, IPO of this company is coming, price band Rs 448-460 per share

New Delhi: The pharmaceutical formulation company Windlas Biotech is going to bring its IPO in the market soon. If you are also planning to invest money in this IPO, then this is the news of your work. You will be able to invest money in it from August 4. This will be the 31st IPO of this year. Let us tell you that in the year 2021, IPO has made investors rich. If you are also planning to earn well then you can invest here.

Windlass Biotech said on Thursday that it has fixed the price for its IPO at Rs 448-460 per share. The company’s IPO will be open for subscription from August 4 to August 6. The lot size will be 30 shares.

Also read: Big IT company will give jobs to 1 lakh people, 41.8 percent increase in income

Can apply for 30 shares
Investors can apply in slots of at least 30 shares and multiples thereof. Under the IPO, new shares worth Rs 165 crore will be issued and an offer for sale will be brought for 51.42 lakh equity shares.

Where will the money be used?
The company will use the capital raised from the IPO to purchase equipment needed to increase the production capacity of the Dehradun-based factory.

This would be the first company of its kind
Let us tell you that if no pharma formulation company is listed in the market yet, then the company can get the benefit of this. If Windlas is listed, it will be the first such company.

Also read: Invest money once in this policy of LIC, you will earn every month throughout your life, know how?

What is the business of the company?
Talking about the business of the company, it is a formulation company. It has been involved in the development and sales of complex generic products from product discovery to its development, licensing and generic products (drugs and nutracells).

Read Hindi News online and watch Live TV News18 on Hindi website. Know news related to country and abroad and your state, Bollywood, sports world, business.

Leave a Reply

Your email address will not be published. Required fields are marked *